Table 3 “Standard of care” regimens for non-cirrhotic, treatment naïve patients with HCV Genotype 1, and cost per SVR

Pegasys + Ribavirin x48 weeks

41 %

$41,758

$101,849

Telaprevir + PegIFN + Ribavirin x24 weeks

75 %

$86,843

$115,791

Sofosbuvir + PegIFN + Ribavirin x12 weeks

90 %

$94,421

$104,912

Sofosbuvir + Ledipasvir x12 weeks

99 %

$94,500

$95,454

Grazoprevir + Elbasvir x12 weeks

94 %

$54,600

$58,085